Abstract
Background
To determine unicompartmental (UKR) and total knee replacement (TKR) revision rates, compare UKR revision rates with what they would have been had they received TKR instead, subsequent re-revision and 90-day mortality rates.
Methods
Using National Joint Registry data, we estimated UKR and TKR revision and mortality rates. Flexible Parametric Survival modelling (FPM) was used to model failure in TKR and make estimates for UKR. Kaplan-Meier estimates were used to compare cumulative re-revision for revised UKRs and TKRs.
Results
10-year UKR revision rates were 2.5-times higher than expected from TKR, equivalent to 70 excess revisions/1,000 cases within 10-years (5,861 excess revisions in this cohort). Revision rates were 2.5 times higher for the highest quartile volume UKR surgeons compared to the same quartile for TKR, and 3.9 times higher for the lowest quartiles respectively. Re-revision rates of revised TKRs (10-years=17.5%; 95%CI=16.4,18.7) were similar to revised UKRs (15.2%; 95%CI=13.4,17.1) and higher than revision rates following primary TKR (3.3%, 95%CI=3.1,3.5). 90-day mortality rates were lower after UKR compared with TKR (0.08% vs. 0.33%) and lower than predicted had UKR patients received a TKR (0.18%), equivalent to 1 fewer death per 1,000 cases.
Conclusions
UKR revision rates were substantially higher than TKR even when demographics and caseload differences were accounted for, however fewer deaths occur after UKR. This should be considered when forming treatment guidelines and commissioning services. Re-revision rates were similar between revised UKRs and TKRs, but considerably higher than for primary TKR, therefore UKR cannot be considered an intermediate procedure.
To determine unicompartmental (UKR) and total knee replacement (TKR) revision rates, compare UKR revision rates with what they would have been had they received TKR instead, subsequent re-revision and 90-day mortality rates.
Methods
Using National Joint Registry data, we estimated UKR and TKR revision and mortality rates. Flexible Parametric Survival modelling (FPM) was used to model failure in TKR and make estimates for UKR. Kaplan-Meier estimates were used to compare cumulative re-revision for revised UKRs and TKRs.
Results
10-year UKR revision rates were 2.5-times higher than expected from TKR, equivalent to 70 excess revisions/1,000 cases within 10-years (5,861 excess revisions in this cohort). Revision rates were 2.5 times higher for the highest quartile volume UKR surgeons compared to the same quartile for TKR, and 3.9 times higher for the lowest quartiles respectively. Re-revision rates of revised TKRs (10-years=17.5%; 95%CI=16.4,18.7) were similar to revised UKRs (15.2%; 95%CI=13.4,17.1) and higher than revision rates following primary TKR (3.3%, 95%CI=3.1,3.5). 90-day mortality rates were lower after UKR compared with TKR (0.08% vs. 0.33%) and lower than predicted had UKR patients received a TKR (0.18%), equivalent to 1 fewer death per 1,000 cases.
Conclusions
UKR revision rates were substantially higher than TKR even when demographics and caseload differences were accounted for, however fewer deaths occur after UKR. This should be considered when forming treatment guidelines and commissioning services. Re-revision rates were similar between revised UKRs and TKRs, but considerably higher than for primary TKR, therefore UKR cannot be considered an intermediate procedure.
Original language | English |
---|---|
Pages (from-to) | 471-477.e6 |
Number of pages | 7 |
Journal | Journal of Arthroplasty |
Volume | 36 |
Issue number | 2 |
Early online date | 7 Sept 2020 |
DOIs | |
Publication status | Published - 1 Feb 2021 |
Bibliographical note
Funding Information:Funding: This article presents independent research funded by the Healthcare Quality Improvement Partnership , National Joint Registry , and by grant 20894 from Arthritis Research UK. This study was supported by the NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health and Social Care. The funder had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript beyond the contribution of the listed co-authors.
Funding Information:
Funding: This article presents independent research funded by the Healthcare Quality Improvement Partnership, National Joint Registry, and by grant 20894 from Arthritis Research UK. This study was supported by the NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health and Social Care. The funder had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript beyond the contribution of the listed co-authors.
Publisher Copyright:
© 2020 Elsevier Inc.
Keywords
- outcomes
- mortality
- revision rates
- total knee replacement
- unicompartmental knee